Company / Shares Outstanding
ENANTA PHARMACEUTICALS INC Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
21.2M
FY2025
5-year range
20.1M / 21.2M
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 9 consecutive years, from 18716834.00 in FY2016 to 21194000.00 in FY2025.
Based on SEC 10-K filings.
21194000.00 in FY2025 with a 5-year CAGR of +1.5%.
Remained stable around 21194000.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 0.6% year-over-year.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.2M | +0.6% |
| FY2024 | 21.1M | +1.3% |
| FY2023 | 20.8M | +2.7% |
| FY2022 | 20.2M | +0.8% |
| FY2021 | 20.1M | +1.9% |
| FY2020 | 19.7M | +1.6% |
| FY2019 | 19.4M | +1.4% |
| FY2018 | 19.1M | +0.4% |
| FY2017 | 19.0M | +1.7% |
| FY2016 | 18.7M | +0.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026